Literature DB >> 24777096

Inhibitor-resistant TEM- and OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates.

Jesús Oteo1, Juan José González-López2, Adriana Ortega3, J Natalia Quintero-Zárate2, Germán Bou4, Emilia Cercenado5, María Carmen Conejo6, Luis Martínez-Martínez7, Ferran Navarro8, Antonio Oliver9, Rosa M Bartolomé2, José Campos10.   

Abstract

In a previous prospective multicenter study in Spain, we found that OXA-1 and inhibitor-resistant TEM (IRT) β-lactamases constitute the most common plasmid-borne mechanisms of genuine amoxicillin-clavulanate (AMC) resistance in Escherichia coli. In the present study, we investigated the population structure and virulence traits of clinical AMC-resistant E. coli strains expressing OXA-1 or IRT and compared these traits to those in a control group of clinical AMC-susceptible E. coli isolates. All OXA-1-producing (n = 67) and IRT-producing (n = 45) isolates were matched by geographical and temporal origin to the AMC-susceptible control set (n = 56). We performed multilocus sequence typing and phylogenetic group characterization for each isolate and then studied the isolates for the presence of 49 virulence factors (VFs) by PCR and sequencing. The most prevalent clone detected was distinct for each group: group C isolates of sequence type (ST) 88 (C/ST88) were the most common in OXA-1 producers, B2/ST131 isolates were the most common in IRT producers, and B2/ST73 isolates were the most common in AMC-susceptible isolates. The median numbers of isolates per ST were 3.72 in OXA-1 producers, 2.04 in IRT producers, and 1.69 in AMC-susceptible isolates; the proportions of STs represented by one unique isolate in each group were 19.4%, 31.1%, and 48.2%, respectively. The sum of all VFs detected, calculated as a virulence score, was significantly higher in AMC-susceptible isolates than OXA-1 and IRT producers (means, 12.5 versus 8.3 and 8.2, respectively). Our findings suggest that IRT- and OXA-1-producing E. coli isolates resistant to AMC have a different and less diverse population structure than AMC-susceptible clinical E. coli isolates. The AMC-susceptible population also contains more VFs than AMC-resistant isolates.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24777096      PMCID: PMC4068566          DOI: 10.1128/AAC.02738-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  36 in total

1.  Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations.

Authors:  P Duriez; O Clermont; S Bonacorsi; E Bingen; A Chaventré; J Elion; B Picard; E Denamur
Journal:  Microbiology       Date:  2001-06       Impact factor: 2.777

2.  Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli.

Authors:  Eva Moreno; Guillem Prats; Montserrat Sabaté; Teresa Pérez; James R Johnson; Antonia Andreu
Journal:  J Antimicrob Chemother       Date:  2006-01-03       Impact factor: 5.790

3.  Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts.

Authors:  Juan P Horcajada; Sara Soto; Abby Gajewski; Alex Smithson; M Teresa Jiménez de Anta; Josep Mensa; Jordi Vila; James R Johnson
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

4.  [Characterization of Escherichia coli isolates derived from phylogenetic groups A and B1 causing extraintestinal infection].

Authors:  Eva Moreno; Guillem Prats; Irene Planells; Ana M Planes; Teresa Pérez; Antonia Andreu
Journal:  Enferm Infecc Microbiol Clin       Date:  2006-10       Impact factor: 1.731

5.  Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise.

Authors:  J R Johnson; A L Stell
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

6.  Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects.

Authors:  Mark R Sannes; Michael A Kuskowski; Krista Owens; Abby Gajewski; James R Johnson
Journal:  J Infect Dis       Date:  2004-11-15       Impact factor: 5.226

7.  Are quinolone-resistant uropathogenic Escherichia coli less virulent?

Authors:  Jordi Vila; Karine Simon; Joaquin Ruiz; Juan P Horcajada; Maria Velasco; Margarita Barranco; Antonio Moreno; Josep Mensa
Journal:  J Infect Dis       Date:  2002-09-13       Impact factor: 5.226

8.  Epidemiological and clinical complexity of amoxicillin-clavulanate-resistant Escherichia coli.

Authors:  Jesús Rodríguez-Baño; Jesús Oteo; Adriana Ortega; Macarena Villar; M Carmen Conejo; Germán Bou; Maitane Aranzamendi-Zaldumbide; Emilia Cercenado; Mercè Gurguí; Luis Martínez-Martínez; María Merino; Alba Rivera; Antonio Oliver; Irene Weber; Alvaro Pascual; Rosa M Bartolomé; Juan José Gónzalez-López; José Campos
Journal:  J Clin Microbiol       Date:  2013-05-01       Impact factor: 5.948

9.  The link between phylogeny and virulence in Escherichia coli extraintestinal infection.

Authors:  B Picard; J S Garcia; S Gouriou; P Duriez; N Brahimi; E Bingen; J Elion; E Denamur
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

10.  Antimicrobial-resistant invasive Escherichia coli, Spain.

Authors:  Jesús Oteo; Edurne Lázaro; Francisco J de Abajo; Fernando Baquero; José Campos
Journal:  Emerg Infect Dis       Date:  2005-04       Impact factor: 6.883

View more
  9 in total

1.  Comparison of Commensal and Clinical Isolates for Diversity of Plasmids in Escherichia coli and Klebsiella pneumoniae.

Authors:  Paula Espinal; Ferran Navarro; Judith Rodríguez-Navarro; Elisenda Miró; Maryury Brown-Jaque; Juan Carlos Hurtado; Albert Moreno; Maite Muniesa; Juan José González-López; Jordi Vila
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

2.  The Carbapenemase-Producing Klebsiella pneumoniae Population Is Distinct and More Clonal than the Carbapenem-Susceptible Population.

Authors:  Andrés Esteban-Cantos; Belén Aracil; Verónica Bautista; Adriana Ortega; Noelia Lara; David Saez; Sara Fernández-Romero; María Pérez-Vázquez; Ferran Navarro; Hajo Grundmann; José Campos; Jesús Oteo
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 3.  Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysis.

Authors:  M J D Dautzenberg; M R Haverkate; M J M Bonten; M C J Bootsma
Journal:  BMJ Open       Date:  2016-03-17       Impact factor: 2.692

4.  Prevalence and characteristics of ST131 clone among unselected clinical Escherichia coli in a Chinese university hospital.

Authors:  Bin Li; Yanfang Lu; Fangjun Lan; Qingwen He; Chen Li; Yingping Cao
Journal:  Antimicrob Resist Infect Control       Date:  2017-11-15       Impact factor: 4.887

5.  Whole Genome Sequencing of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli Isolated From a Wastewater Treatment Plant in China.

Authors:  Xiawei Jiang; Xinjie Cui; Hao Xu; Wenhong Liu; Fangfang Tao; Tiejuan Shao; Xiaoping Pan; Beiwen Zheng
Journal:  Front Microbiol       Date:  2019-08-02       Impact factor: 5.640

Review 6.  Escherichia coli β-Lactamases: What Really Matters.

Authors:  Priyanka Bajaj; Nambram S Singh; Jugsharan S Virdi
Journal:  Front Microbiol       Date:  2016-03-30       Impact factor: 5.640

7.  Carbapenemase-producing enterobacteriaceae recovered from a Spanish river ecosystem.

Authors:  Núria Piedra-Carrasco; Anna Fàbrega; William Calero-Cáceres; Thais Cornejo-Sánchez; Maryury Brown-Jaque; Alba Mir-Cros; Maite Muniesa; Juan José González-López
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

8.  Clonal Structure, Virulence Factor-encoding Genes and Antibiotic Resistance of Escherichia coli, Causing Urinary Tract Infections and Other Extraintestinal Infections in Humans in Spain and France during 2016.

Authors:  Saskia-Camille Flament-Simon; Marie-Hélène Nicolas-Chanoine; Vanesa García; Marion Duprilot; Noémie Mayer; María Pilar Alonso; Isidro García-Meniño; Jesús E Blanco; Miguel Blanco; Jorge Blanco
Journal:  Antibiotics (Basel)       Date:  2020-04-04

9.  Prevalence and molecular characteristics of sequence type 131 clone among clinical uropathogenic Escherichia coli isolates in Riyadh, Saudi Arabia.

Authors:  Abdulaziz Alqasim; Ahmad Abu Jaffal; Abdullah A Alyousef
Journal:  Saudi J Biol Sci       Date:  2019-09-18       Impact factor: 4.219

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.